Non-contrast-enhanced multiparametric cardiac magnetic resonance reveals coronary microvascular functional and structural obstruction after percutaneous coronary intervention - Report - MDSpire

Non-contrast-enhanced multiparametric cardiac magnetic resonance reveals coronary microvascular functional and structural obstruction after percutaneous coronary intervention

  • By

  • Hideo Arai

  • Masateru Kawakubo

  • Pandji Triadyaksa

  • Adi Wibowo

  • Kenichi Sanui

  • Hiroshi Nishimura

  • Toshiaki Kadokami

  • March 17, 2025

  • 0 min

Share

Multiparametric CMR Without Contrast Enhances Detection of CMVO Post-PCI

Overview

This study demonstrates that multiparametric cardiac magnetic resonance (CMR) imaging without contrast media (CM) can effectively diagnose coronary microvascular obstruction (CMVO) in patients after percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). The approach offers a noninvasive alternative to traditional contrast-enhanced methods, particularly beneficial for patients with renal impairment.

Background

Cardiovascular diseases remain the leading cause of death globally, with acute coronary syndrome patients often experiencing poor prognosis despite early PCI. Coronary microvascular obstruction (CMVO), or 'no-reflow,' contributes significantly to adverse outcomes but is inadequately assessed by coronary angiography. While early gadolinium enhancement (EGE) with contrast media is the current standard for CMVO detection, its use is limited in patients with renal dysfunction. Multiparametric CMR without contrast has emerged as a promising diagnostic tool to overcome these limitations.

Data Highlights

The study retrospectively enrolled patients with AMI undergoing PCI within 24 hours of onset, excluding those with severe renal impairment (eGFR < 30). Multiparametric CMR imaging included cine imaging, T2 and T2* mapping before contrast administration, and EGE and late gadolinium enhancement (LGE) imaging after contrast. CMVO was identified as hypo-intense regions on EGE within infarcted myocardium on LGE. Clinical parameters and detailed CMR measurements such as left ventricular volumes, ejection fraction, mass index, and circumferential strain were recorded and analyzed.

Key Findings

  • Multiparametric CMR without contrast successfully identified CMVO regions correlating with those detected by traditional contrast-enhanced methods.
  • CMVO was present in approximately half of patients despite achieving TIMI grade 3 flow post-PCI, highlighting limitations of angiography alone.
  • Non-contrast T2 and T2* mapping provided valuable information on microvascular dysfunction and myocardial structural impairment.
  • Multiparametric CMR parameters correlated with clinical and functional indices such as left ventricular ejection fraction and circumferential strain.
  • The method is particularly advantageous for patients with renal impairment who are at risk from gadolinium-based contrast agents.

Clinical Implications

Multiparametric CMR without contrast offers a safe, noninvasive, and effective alternative for diagnosing CMVO in AMI patients post-PCI, especially those with contraindications to contrast media. This technique may improve risk stratification and guide management by detecting microvascular dysfunction and structural myocardial damage not visible on angiography. Incorporating multiparametric CMR into clinical practice could enhance prognostic assessment and therapeutic decision-making.

Conclusion

Multiparametric CMR without contrast enhances detection of coronary microvascular dysfunction and structural impairment following PCI, providing a valuable diagnostic tool that overcomes limitations of contrast use. This approach holds promise for improving outcomes in patients with acute myocardial infarction.

References

  1. World Health Organization 2021 -- Cardiovascular diseases (CVDs)
  2. Studies 2,3 -- Prognosis in acute coronary syndrome despite PCI
  3. Studies 4,5,6 -- Mechanisms of coronary microvascular obstruction
  4. Study 7 -- CMVO prevalence despite TIMI grade 3 flow
  5. Study 8 -- Cardiac magnetic resonance for CMVO detection
  6. Studies 9,10 -- CMVO association with adverse outcomes
  7. Study 11 -- Renal dysfunction limiting contrast use
  8. Study 12 -- Multiparametric CMR in clinical practice
  9. Study 13 -- Validation of feature-tracking software for strain analysis

Original Source(s)

Related Content